Preventing Preeclampsia by Silencing Soluble Flt‐1?
暂无分享,去创建一个
[1] M. Moore,et al. RNAi Modulation of Placental sFLT1 for the Treatment of Preeclampsia. , 2018, Nature Biotechnology.
[2] D. Charnock-Jones,et al. Placental hypoxia, endoplasmic reticulum stress and maternal endothelial sensitisation by sFLT1 in pre-eclampsia , 2016, Journal of reproductive immunology.
[3] I. Konishi,et al. Case of soluble fms‐like tyrosine kinase 1 apheresis in severe pre‐eclampsia developed at 15 weeks’ gestation , 2015, The journal of obstetrics and gynaecology research.
[4] T. Libermann,et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. , 2003, The Journal of clinical investigation.
[5] J. Scott,et al. IMMUNOLOGY OF PRE-ECLAMPSIA , 1978, The Lancet.